Novamind announces an LOI to add two Arizona mental health clinics to its treatment network.

The States Reform Act seeks to end the federal prohibition of cannabis.

The bill would encourage research into psilocybin, the active ingredient in magic mushrooms.

Psychedelic companies feel that Compass Pathways results validate efforts to develop next-generation medicine for treating mental health issues.

Psychedelic medicine is both extremely efficacious and highly cost-effective. It is also an absolute necessity to RESCUE the economy.

Compass Pathways revealed psychedelic drugs were highly effective as a therapy for treatment-resistant depression.

If these states do move forward with the legalization of adult use recreational cannabis, the fight for the end of nationwide cannabis prohibition could be reaching its finale.

atai Life Sciences reports its Q3 2021 financial results. Continued progress across 11 therapeutic research programs. Cash and equivalents of $430.3 million as of September 30, 2021.

atai Life Sciences reports its Q3 2021 financial results. Continued progress across 11 therapeutic research programs. Cash and equivalents of $430.3 million as of September 30, 2021.

MindMed announces its Q3 2021 results. Continued progress on R&D and pipeline development. Cash and equivalents of $178.6 million.